BEAS-2B Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | BEAS-2B is an immortalized cell line derived from the bronchial epithelium of a non-cancerous individual. This cell line was established by transforming human bronchial epithelial cells with an adenovirus 12-SV40 hybrid virus, which confers the cells with an extended lifespan while maintaining many of the morphological and functional characteristics typical of primary bronchial epithelial cells. BEAS-2B cells are widely used in respiratory disease research, particularly in studies related to the toxicological and pharmacological effects of inhalable substances, owing to their origin from the airway epithelium. The cell line exhibits a cobblestone morphology when cultured and retains certain critical features, such as the ability to metabolize xenobiotic compounds, making them highly relevant for studies on drug metabolism and respiratory toxicology. They have also been employed extensively in studies exploring cellular mechanisms of asthma, chronic obstructive pulmonary disease (COPD), and cancer. BEAS-2B cells respond predictably to cytokines, oxidative stress, and other stimuli typical of respiratory tract exposure to environmental agents. This makes them a valuable model for studying inflammation and oxidative stress mechanisms in pulmonary cells. As a tool in biomedical research, BEAS-2B cells are also frequently used to assess carcinogenic potential of airborne particles, where they serve as a model to understand the changes in airway epithelial cells following exposure to carcinogens. Their genetic makeup and susceptibility to genetic manipulation further enhance their utility in molecular biology experiments aimed at understanding gene expression and signaling pathways involved in lung diseases and cancer development. |
|---|---|
| Organism | Human |
| Tissue | Lung, Bronchus |
| Synonyms | Beas-2B, BEAS 2B, BEAS2B, Beas2B, Bronchial Epithelium transformed with Ad12-SV40 2B |
Characteristics
| Age | Age unspecified |
|---|---|
| Gender | Male |
| Morphology | Epithelial-like |
| Growth properties | Adherent |
Regulatory Data
| Citation | BEAS-2B (Cytion catalog number 300311) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_0168 |
| GMO Status | GMO-S1: This human bronchial epithelial cell line (BEAS-2B) contains an Ad12-SV40 hybrid construct introduced by transfection, enabling immortalization without viral particle release. The hybrid adenovirus/SV40 insert is stably integrated. This classification applies only within Germany and may differ elsewhere. |
Biomolecular Data
| Viruses | Ad12-SV40 hybrid virus |
|---|---|
| Products | Keratins, SV-40 T antigen |
Handling
| Culture Medium | Airway Epithelial Cell Basal Medium (PromoCell GmbH) |
|---|---|
| Supplements | Supplement the medium with Growth Medium Supplement Mix (PromoCell GmbH) |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300311-041223 | Certificate of Analysis | 23. May. 2025 | 300311 |
| 300311-041223SF | Certificate of Analysis | 23. May. 2025 | 300311 |
| 300311-030425 | Certificate of Analysis | 23. May. 2025 | 300311 |
-
Required products
Required products
Antibiotic/Antimycotic Solution (100x)Product Overview
Volume: 100 ml
Storage: ≤-15°C
Sterility: Sterile-filtered
Antibiotic/Antimycotic Solution (100x) is a sterile, ready-to-use concentrate designed to reduce microbial contamination risks in cell culture and related laboratory applications. This 100x solution contains a well-established combination of penicillin, streptomycin, and amphotericin B—providing broad-spectrum antimicrobial activity against Gram-positive and Gram-negative bacteria, yeasts, and filamentous fungi. The formulation is suitable for use in eukaryotic cell cultures, bacterial media, and other contamination-sensitive systems, supporting clean and consistent lab operations.
Application and Benefits Optimized for routine research protocols, this solution is widely used to maintain aseptic conditions in cell culture workflows. It offers reliable performance in contamination-sensitive environments, helping researchers reduce the risk of microbial overgrowth without compromising cell health or experimental reproducibility. The sterile-filtered formulation eliminates the need for additional solubilization steps, supporting streamlined media preparation and reducing variability in daily lab procedures.
Usage and Compatibility To achieve standard working concentrations, dilute the solution 1:100 into your complete culture medium. The product is compatible with a broad range of mammalian cell lines and basal media. With consistent stock availability, researchers benefit from dependable supply continuity and simplified logistics planning. The solution should be stored at ≤ –15 °C and protected from repeated freeze-thaw cycles to maintain stability. For research use only. Not for use in diagnostic or therapeutic procedures. Not for use in humans or animals.USD$45.00* -
Related products
Related products